IBRN (iShares Neuroscience and Healthcare ETF) Stock Analysis - Financials

iShares Neuroscience and Healthcare ETF (IBRN) is a publicly traded the market company. As of May 21, 2026, IBRN trades at $28.16 with a market cap of $0 and a P/E ratio of 0.00. IBRN moved +0.89% today. Year to date, IBRN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are IBRN's key financials?

IBRN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IBRN recently traded at $28.16. Market cap is $0. P/E ratio is 0.00. Revenue is $0.

IBRN Key Metrics

Key financial metrics for IBRN
MetricValue
Price$28.16
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

IBRN Analyst Consensus

IBRN analyst coverage data. Average price target: $0.00.

Common questions about IBRN

What are IBRN's key financials?
IBRN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IBRN recently traded at $28.16. Market cap is $0. P/E ratio is 0.00. Revenue is $0.
Is IBRN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBRN. It does not provide personalized investment advice.
IBRN

IBRN